Ingro Finanz AG

investment firm

About

Ingro Finanz AG is an investment holding company specialized in late stage venture investments.

  • Bubendorf,Basel-Landschaft,Switzerland

Details

Operating Status
Active
Investor Type
Venture Capital

Ingro Finance AG is a privately held Swiss company focusing on the purchase,
administration and divestment of all types of participations. The investment portfolio of the
company comprises amongst others participations in various life science companies.

Investments

Number of Investments
Number of Lead Investments
2
0
Ingro Finanz AG has made 2 investments. Their most recent investment was on May 12, 2009, when NovImmune raised $54.80M.
Date Company Name
Round Money Raised Industry Lead Investor
May 12, 2009 NovImmune
Series Unknown $54.80M Biotechnology
Series C €33.70M Biopharma

Exits

Ingro Finanz AG has had 1 exits. Ingro Finanz AG most notable exits include Ganymed Pharmaceuticals

Date Company Name Exit Type Industry
Oct 28, 2016 Ganymed Pharmaceuticals M&A Biopharma Detail